Economic impact of chronic prostatitis

被引：47

作者：

Duloy A.M.S. ^{[1
]}

Calhoun E.A. ^{[1
]}

Clemens J.Q. ^{[1
]}

机构：

[1] Northwestern University Feinberg School of Medicine, Chicago, IL 60611, 303 E. Chicago Avenue

来源：

Current Urology Reports | 2007年 / 8卷 / 4期

基金：

美国国家卫生研究院;

关键词：

Prostatitis; Visit Rate; Ambulatory Surgery; Chronic Prostatitis; Pelvic Pain Syndrome;

D O I：

10.1007/s11934-007-0081-x

中图分类号：

学科分类号：

摘要：

There are four types of prostatitis, including type I (acute bacterial prostatitis), type II (chronic bacterial prostatitis), type 111 (chronic prostatitis/chronic pelvic pain syndrome, or CP/CPPS), and type IV (asymptomatic inflammatory prostatitis). These prostatitis conditions account for approximately 2 million office visits each year to primary care physicians and urologists. The annual cost to treat prostatitis is approximately $84 million. Compared with control subjects, men with prostatitis incur significantly greater costs, predominantly due to increased outpatient visits and pharmacy expenses. CP/CPPS is the most common type of prostatitis. The condition is characterized by chronic, idiopathic pelviperineal pain. Due to the lack of effective treatments for CP/CPPS, the per-person costs associated with the condition are substantial and are similar to those reported for peripheral neuropathy, low back pain, fibromyalgia, and rheumatoid arthritis. Costs appear to be higher in men with more severe symptoms. Indirect costs (eg, work and productivity loss) are incurred by many patients with CP/CPPS. Identification of effective treatments for CP/CPPS would be expected to substantially reduce the costs associated with the condition. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：336 / 339

页数：3

共 14 条

[1]

Krieger J.N., Nyberg Jr L., Nickel J.C., NIH consensus definition and classification of prostatitis, JAMA, 282, pp. 236-237, (1999)

[2]

Clemens J.Q., Meenan R.T., O'Keeffe Rosetti M.C., Et al., Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community, J Urol, 174, pp. 2319-2322, (2005)

[3]

Collins M.M., Stafford R.S., O'Leary M.P., Barry M.J., How common is prostatitis? A national survey of physician visits, J Urol, 159, pp. 1224-1228, (1998)

[4]

Roberts R.O., Lieber M.M., Rhodes T., Et al., Prevalence of a physician-assigned diagnosis of prostatitis: The Olmsted County Study of Urinary Symptoms and Health Status Among Men, Urology, 51, pp. 578-584, (1998)

[5]

Mehik A., Hellstrom P., Lukkarinen O., Et al., Epidemiology of prostatitis in Finnish men: A population-based cross-sectional study, BJU Int, 86, pp. 443-448, (2000)

[6]

Collins M.M., Meigs J.B., Barry M.J., Et al., Prevalence and correlates of prostatitis in the Health Professionals Follow-Up Study cohort, J Urol, 167, pp. 1363-1366, (2002)

[7]

Moon T.D., Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis, Urology, 50, pp. 543-547, (1997)

[8]

Cheah P.Y., Liong M.L., Yuen K.H., Et al., Chronic prostatitis: Symptom survey with follow-up clinical evaluation, Urology, 61, pp. 60-64, (2003)

[9]

Nickel J.C., Downey J., Hunter D., Clark J., Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index, J Urol, 165, pp. 842-845, (2001)

[10]

Roberts R.O., Jacobson D.J., Girman C.J., Et al., Prevalence of prostatitis-like symptoms in a community based cohort of older men, J Urol, 168, pp. 2467-2471, (2002)

← 1 2 →